Antiphospholipid antibodies are enriched post-acute COVID-19 but do not modulate the thrombotic risk.
Emmenegger M, Emmenegger V, Shambat SM, Scheier TC, Gomez-Mejia A, Chang CC, Wendel-Garcia PD, Buehler PK, Buettner T, Roggenbuck D, Brugger SD, Frauenknecht KBM.
Emmenegger M, et al. Among authors: emmenegger v.
Clin Immunol. 2023 Dec;257:109845. doi: 10.1016/j.clim.2023.109845. Epub 2023 Nov 22.
Clin Immunol. 2023.
PMID: 37995947
Free article.